LEVETIRACETAM | A215465 | KNACK PHARMACEUTICALS INC
1 strength0 unique patents0 unique exclusivities
Products (1)
No patent or exclusivity listings for this strength.
MODIFIEDtype7/1/2026
Levetiracetam (KNACK, NDA 215465) transitioned from prescription to discontinued status in the FDA database.
MODIFIEDTE Code7/1/2026
Knack's levetiracetam (Levetiracetam, NDA 215465) therapeutic equivalence code changed from AP to a new designation.